Panacea Venture
Panacea Venture is a life sciences-focused venture capital firm spun out from Kleiner Perkins that invests across company formation, expansion, and public market stages via three USD funds and a portfolio of 35+ companies.
- Company typePrivate
- Founded2017
- HeadquartersGrand Cayman, Cayman Islands
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Panacea Venture does
Panacea Venture, doing business as Panacea Capital, is a healthcare-focused venture capital firm founded in 2017 and headquartered in Grand Cayman, Cayman Islands. The firm was spun out of Kleiner Perkins and has built a global life sciences investment practice, deploying capital through three USD-denominated funds sourced from institutional investors and strategic limited partners. Its investment model spans the full company lifecycle, from formation-stage incubation through expansion-stage growth to public-market investing, addressing funding gaps and strategic guidance needs for clinical-stage and early-stage life sciences companies.
Panacea Venture manages a portfolio of more than 30 private companies and several public companies, totaling approximately 35+ portfolio companies. Named investments span next-generation immunotherapy (Actym Therapeutics), regenerative medicine (Eos BioInnovation), and neurodegenerative disease therapeutics (Myrtelle), as well as public-market positions such as Connect Biopharma, Human Longevity, and Kainova Therapeutics. The firm employs 51-100 staff, including 19+ partners and venture partners with over 100 years of combined life sciences and operating experience.
The business model is a classic venture capital structure: the firm generates revenue through management fees (typically charged on committed or invested capital across its three USD funds) and carried interest on successful portfolio exits. It does not develop proprietary technology; rather, its core "product" is capital allocation, strategic guidance, and network access for portfolio companies. The firm supports portfolio companies in clinical development, cross-border expansion, and capital markets readiness, leveraging its Kleiner Perkins heritage for deal flow and LP credibility.
Panacea Venture firmographics
Firmographics- Name
- Panacea Venture
- Legal name
- Panacea Capital
- Website
- https://panaceaventure.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Panacea Venture is a life sciences-focused venture capital firm spun out from Kleiner Perkins that invests across company formation, expansion, and public market stages via three USD funds and a portfolio of 35+ companies.
- Ownership category
- akta.pro rank
Panacea Venture industry classification
Industry- Product category
- Venture Capital - Life Sciences
- NAICS
- Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259), Funds, Trusts, and Other Financial Vehicles (525)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Venture Capital Fund-of-Funds / Multi-Manager Platforms (FSANAAAJ)
Keywords
Where Panacea Venture is headquartered
LocationHeadquarters
- HQ city
- Grand Cayman
- HQ country
- Cayman Islands
Markets served
Panacea Venture business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Marketing channels2 records
Panacea Venture product offering
Product offeringCore offering
Panacea Venture is a life sciences-focused venture capital firm that invests in and incubates early-stage and clinical-stage healthcare companies across company formation, expansion stage, and public market investing. It manages three USD funds raised from institutional and strategic investors, with a portfolio of more than 30 private companies and several public companies. The firm provides both capital and strategic company-building support to portfolio companies developing innovative therapeutics and breakthrough technologies.
Product overview
Panacea Venture is a life sciences venture capital firm spun out from Kleiner Perkins, offering a single unified venture investment service across three USD funds. The firm manages a portfolio of 35+ private companies and several public companies, with investments spanning immunotherapy, regenerative medicine, and neurodegenerative disease treatments through portfolio companies including Actym Therapeutics, Eos BioInnovation, and Myrtelle.
Differentiator
Problem solved
Functional benefit
Products and services
- Venture Capital Investment Services Panacea Venture's core service: deploying capital from three USD funds into early-stage and clinical-stage life sciences companies, with active strategic support from company formation through expansion stage to public market investing. Targeted at founders and executives of innovative therapeutics, biotech, and healthcare companies.
Companies that use Panacea Venture
Customer profileSegments1 record
Ideal customer profiles1 record
Panacea Venture technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Panacea Venture partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights4 records
Panacea Venture competitors and assessment
Company assessmentDirect peers
- ARCH Venture Partners: Long-tenured early-stage science and biotech investor founding companies out of academic research — closely comparable to Panacea's formation-stage life sciences strategy.
- Bain Capital Life Sciences: Healthcare-dedicated platform investing across venture, growth, and public equities in biopharma — a directly comparable multi-stage life sciences franchise.
- OrbiMed Advisors: One of the largest dedicated healthcare investment firms globally, investing across stages from venture to public markets in biopharma, medical devices, and diagnostics — a directly comparable specialist to Panacea.
- RA Capital Management: Healthcare-focused investment manager with crossover and venture strategies spanning private and public biopharma, providing a directly comparable specialist life sciences franchise to Panacea.
- Versant Ventures: Healthcare-focused venture firm investing across biopharma, medical devices, and diagnostics from formation through public markets — directly comparable in stage coverage and therapeutic focus.
- Atlas Venture: Early-stage life sciences venture firm that builds companies from inception across therapeutics modalities — a directly comparable formation-stage specialist to Panacea.
- Foresite Capital: Healthcare and biotech-focused investment firm investing across private and public companies from formation to commercialization — directly comparable in stage and sector.
- 5AM Ventures: Early-stage life sciences venture firm building companies in therapeutics and platforms — directly comparable formation-stage life sciences specialist.
- Andreessen Horowitz Bio + Health: Dedicated bio/healthcare fund from a major tech-focused venture franchise, investing across therapeutics, digital health, and biotech platforms — a comparable cross-stage specialist competing for similar deal flow.
Broad incumbents
- Kleiner Perkins: Panacea's parent franchise at spin-out; a broad technology and healthcare investor with crossover capabilities, providing brand, network, and co-investment context for Panacea's positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Panacea Venture social profiles
Digital presencePanacea Venture financial estimates
Financial estimateRevenue estimate
Valuation estimate
Panacea Venture leadership team
Management profileNumber of profiles
Profiles1 record
Panacea Venture funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Panacea Venture M&A and investment
M&A and investmentM&A
Investments22 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Panacea Venture
What does Panacea Venture do?
Panacea Venture is a life sciences-focused venture capital firm that invests in and incubates early-stage and clinical-stage healthcare companies across company formation, expansion stage, and public market investing. It manages three USD funds raised from institutional and strategic investors, with a portfolio of more than 30 private companies and several public companies. The firm provides both capital and strategic company-building support to portfolio companies developing innovative therapeutics and breakthrough technologies.
Is Panacea Venture a public or private company?
Panacea Venture is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Panacea Venture founded?
Panacea Venture was founded in 2017. It employs 51 to 100 people.
Where is Panacea Venture based?
Panacea Venture is headquartered in Grand Cayman, Cayman Islands.
Who are Panacea Venture's main competitors?
Direct peers on record are ARCH Venture Partners, Bain Capital Life Sciences, OrbiMed Advisors, RA Capital Management, Versant Ventures, Atlas Venture, Foresite Capital, 5AM Ventures and Andreessen Horowitz Bio + Health. Kleiner Perkins is listed as a broad incumbent.
Does Panacea Venture have an API?
No public API is recorded for Panacea Venture.
What industry is Panacea Venture in?
Panacea Venture's product category is Venture Capital - Life Sciences. Its primary akta.pro industry code is FSANAAAJ, Venture Capital Fund-of-Funds / Multi-Manager Platforms. Its NAICS code is 523940 and its SIC code is 6282.